Skip to main content

Advertisement

Log in

Self-reported quality of life in users and nonusers of dietary supplements in cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goals of work

To describe the Quality of Life (QoL) characteristics of users of dietary supplements vs nonusers.

Patients and methods

A survey of 225 cancer patients presenting for treatment at Cancer Treatment Centers of America was completed between November 2001 and October 2003. A validated instrument assessed the use of 56 dietary supplements in the past month. Two validated questionnaires assessed QoL. Mean QoL scores were compared between the users and nonusers using univariate and multivariate linear regression.

Results

Of 225 patients, 91 (40%) were males and 134 (60%) females. Sixty seven (30%) had breast cancer, 40 (18%) colorectal cancer, and 32 (14%) lung cancer. One hundred sixty four (73%) had used dietary supplements in the past month, while 61 (27%) had not. Mean European Organization for Research Treatment of Cancer QoL scores were significantly better among the users for physical and emotional function scales and fatigue, nausea, appetite loss, and constipation symptom scales adjusting for tumor site. In the stratified analysis, lung cancer patients did not show any statistically significant differences in QoL scores between the users and nonusers. Colorectal cancer patients demonstrated statistically significant differences in constipation symptom, with dietary supplement users having better QoL. Breast cancer patients demonstrated statistically significant differences in several QoL scale scores between users and nonusers.

Conclusions

Contrary to some of the previously published research, this study, conducted at a community hospital comprehensive cancer center that combines alternative treatment approaches with conventional cancer care, found better self-reported QoL among the users of dietary supplements, as compared to nonusers. The next step in this research is to prospectively evaluate the patterns of changing QoL in relation to dietary supplement use across the entire duration of cancer diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252

    PubMed  Google Scholar 

  2. Eisenberg DM, Davis RB, Ettner SL et al (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280(18):1569–1575

    Article  PubMed  Google Scholar 

  3. Kessler RC, Davis RB, Foster DF et al (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135(4):262–268

    PubMed  Google Scholar 

  4. Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777–782

    Article  PubMed  Google Scholar 

  5. Boon H, Stewart M, Kennard MA et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18(13):2515–2521

    PubMed  Google Scholar 

  6. Correa-Velez I, Clavarino A, Barnett AG, Eastwood H (2003) Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med 17(8):695–703

    PubMed  Google Scholar 

  7. Patterson RE, Neuhouser ML, Hedderson MM et al (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8(4):477–485

    Article  PubMed  Google Scholar 

  8. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514

    PubMed  Google Scholar 

  9. Gupta D, Lis CG, Birdsall TC, Grutsch JF (2005) The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 2005 April 23. DOI 10.1007/s00520-005-0820-9

    Google Scholar 

  10. Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 10(1):52–57

    Google Scholar 

  11. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy–herb interactions in adult cancer patients. Support Care Cancer 12(6):454–462

    Article  PubMed  Google Scholar 

  12. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376

    PubMed  Google Scholar 

  13. Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient–observer agreement. J Clin Epidemiol 50(4):441–450

    Article  PubMed  Google Scholar 

  14. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13(5):1249–1254

    PubMed  Google Scholar 

  15. Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. J Clin Epidemiol 8(1):15–24

    Google Scholar 

  16. Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19

    PubMed  Google Scholar 

  17. Ferrans CE, Powers MJ (1992) Psychometric assessment of the Quality of Life Index. Res Nurs Health 15(1):29–38

    PubMed  Google Scholar 

  18. Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304

    PubMed  Google Scholar 

  19. Warnecke RB, Ferrans CE, Johnson TP et al (1996) Measuring quality of life in culturally diverse populations. J Natl Cancer Inst Monogr (20):29–38

    PubMed  Google Scholar 

  20. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340(22):1733–1739

    Article  PubMed  Google Scholar 

  21. Cassileth BR, Lusk EJ, Guerry D et al (1991) Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 324(17):1180–1185

    PubMed  Google Scholar 

  22. Paltiel O, Avitzour M, Peretz T et al (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19(9):2439–2448

    PubMed  Google Scholar 

  23. Bliley AV, Ferrans CE (1993) Quality of life after coronary angioplasty. Heart Lung 22(3):193–199

    PubMed  Google Scholar 

  24. Johnson CD, Wicks MN, Milstead J, Hartwig M, Hathaway DK (1998) Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Scholarsh 30(2):125–130

    Google Scholar 

  25. Panel on Definition and Description (1997) Defining and describing complementary and alternative medicine. CAM Research Methodology Conference, April 1995. Altern Ther Health Med 3(2):49–57

    Google Scholar 

  26. Chatwin J, Tovey P (2004) Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature. Eur J Cancer Care (Engl) 13(3):210–218

    Article  Google Scholar 

  27. Kaptchuk TJ, Eisenberg DM (2001) Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med 135(3):196–204

    PubMed  Google Scholar 

  28. Zollman C, Vickers A (1999) ABC of complementary medicine. Complementary medicine in conventional practice. BMJ 319(7214):901–904

    PubMed  Google Scholar 

  29. Downer SM, Cody MM, McCluskey P et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309(6947):86–89

    PubMed  Google Scholar 

Download references

Acknowledgements

Drs. Gupta and Grutsch had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. This study was funded by Cancer Treatment Centers of America (CTCA). Design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript were conducted by the authors of this study, who take responsibility for its content. We thank Thom Wodek for his assistance with collection and assembly of data and administrative support for this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Digant Gupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lis, C.G., Cambron, J.A., Grutsch, J.F. et al. Self-reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer 14, 193–199 (2006). https://doi.org/10.1007/s00520-005-0876-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-005-0876-6

Keywords

Navigation